Lv6
1640 积分 2025-10-20 加入
Steatotic liver disease and HIV: an agenda for 2030
3天前
已完结
Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents
3天前
已完结
Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort
4个月前
已完结
The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma
4个月前
已完结
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
4个月前
已完结
Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors' assessment
4个月前
已关闭
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase
6个月前
已关闭
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase
6个月前
已关闭
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
6个月前
已完结
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
6个月前
已完结
皖公网安备34019202002308
